Structure Therapeutics Inc. Stock Analysis & AI Score
Structure Therapeutics Inc. (GPCR) has an ST Score of 58.9 (B-), driven by its Financial Strength (A+) and held back by its Growth (F). Analysts rate it Buy with a $90.50 price target (+151.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Structure Therapeutics Inc. (GPCR) has an ST Score of 58.9 (B-), driven by its Financial Strength (A+) and held back by its Growth (F). Analysts rate it Buy with a $90.50 price target (+151.2% upside).
- Strongest
- Financial StrengthA+
- Weakest
- GrowthF
All factor grades
- Financial StrengthA+
- SentimentA+
- ForecastA
- ProfitabilityA-
- ValuationB
- MomentumC
- GrowthF
- Piotroski1/9
Contact
GPCR stock: frequently asked questions
What is GPCR's ST Score?
Structure Therapeutics Inc. (GPCR) has an ST Score of 58.9 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GPCR a buy, hold, or sell?
Analysts rate GPCR a Buy, with a price target of $90.50 (+151.2% vs the current price). Our ST Score grades it B- (58.9/100). The ST Score is a data-driven signal, not a recommendation.
What are GPCR's factor grades?
Valuation B, Profitability A-, Financial Strength A+, Momentum C, Growth F, Forecast A, Sentiment A+.
What is GPCR's valuation grade?
Structure Therapeutics Inc. (GPCR) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GPCR's growth grade?
Structure Therapeutics Inc. (GPCR) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GPCR's profitability grade?
Structure Therapeutics Inc. (GPCR) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GPCR's financial strength grade?
Structure Therapeutics Inc. (GPCR) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GPCR?
The average analyst price target for Structure Therapeutics Inc. (GPCR) is $90.50 from 14 analysts, which is +151.2% versus the recent price of $36.02.
What is GPCR's Piotroski score?
Structure Therapeutics Inc. (GPCR) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.